• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Logo of envhperEnvironmental Health PerspectivesBrowse ArticlesAbout EHPGeneral InformationAuthorsMediaProgramsPartnerships
Environ Health Perspect. May 1999; 107(Suppl 2): 349–355.
PMCID: PMC1566286
Research Article

Biomarkers of environmental tobacco smoke exposure.

Abstract

Biomarkers are desirable for quantitating human exposure to environmental tobacco smoke (ETS) and for predicting potential health risks for exposed individuals. A number of biomarkers of ETS have been proposed. At present cotinine, measured in blood, saliva, or urine, appears to be the most specific and the most sensitive biomarker. In nonsmokers with significant exposure to ETS, cotinine levels in the body are derived primarily from tobacco smoke, can be measured with extremely high sensitivity, and reflect exposure to a variety of types of cigarettes independent of machine-determined yield. Under conditions of sustained exposure to ETS (i.e., over hours or days), cotinine levels reflect exposure to other components of ETS. Supporting the validity of cotinine as a biomarker, cotinine levels have been positively correlated to the risks of some ETS-related health complications in children who are not cigarette smokers.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.4M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Images in this article

Click on the image to see a larger version.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Bartsch H, Caporaso N, Coda M, Kadlubar F, Malaveille C, Skipper P, Talaska G, Tannenbaum SR, Vineis P. Carcinogen hemoglobin adducts, urinary mutagenicity, and metabolic phenotype in active and passive cigarette smokers. J Natl Cancer Inst. 1990 Dec 5;82(23):1826–1831. [PubMed]
  • Hammond SK, Coghlin J, Gann PH, Paul M, Taghizadeh K, Skipper PL, Tannenbaum SR. Relationship between environmental tobacco smoke exposure and carcinogen-hemoglobin adduct levels in nonsmokers. J Natl Cancer Inst. 1993 Mar 17;85(6):474–478. [PubMed]
  • Maclure M, Katz RB, Bryant MS, Skipper PL, Tannenbaum SR. Elevated blood levels of carcinogens in passive smokers. Am J Public Health. 1989 Oct;79(10):1381–1384. [PMC free article] [PubMed]
  • Binková B, Lewtas J, Misková I, Lenícek J, Srám R. DNA adducts and personal air monitoring of carcinogenic polycyclic aromatic hydrocarbons in an environmentally exposed population. Carcinogenesis. 1995 May;16(5):1037–1046. [PubMed]
  • Jahnke GD, Thompson CL, Walker MP, Gallagher JE, Lucier GW, DiAugustine RP. Multiple DNA adducts in lymphocytes of smokers and nonsmokers determined by 32P-postlabeling analysis. Carcinogenesis. 1990 Feb;11(2):205–211. [PubMed]
  • van Maanen JM, Maas LM, Hageman G, Kleinjans JC, van Agen B. DNA adduct and mutation analysis in white blood cells of smokers and nonsmokers. Environ Mol Mutagen. 1994;24(1):46–50. [PubMed]
  • Crawford FG, Mayer J, Santella RM, Cooper TB, Ottman R, Tsai WY, Simon-Cereijido G, Wang M, Tang D, Perera FP. Biomarkers of environmental tobacco smoke in preschool children and their mothers. J Natl Cancer Inst. 1994 Sep 21;86(18):1398–1402. [PubMed]
  • Hecht SS, Carmella SG, Murphy SE, Akerkar S, Brunnemann KD, Hoffmann D. A tobacco-specific lung carcinogen in the urine of men exposed to cigarette smoke. N Engl J Med. 1993 Nov 18;329(21):1543–1546. [PubMed]
  • Adlkofer F, Scherer G, Heller WD. Hydroxyproline excretion in urine of smokers and passive smokers. Prev Med. 1984 Nov;13(6):670–679. [PubMed]
  • Bos RP, Theuws JL, Henderson PT. Excretion of mutagens in human urine after passive smoking. Cancer Lett. 1983 May;19(1):85–90. [PubMed]
  • Mooney LA, Santella RM, Covey L, Jeffrey AM, Bigbee W, Randall MC, Cooper TB, Ottman R, Tsai WY, Wazneh L, et al. Decline of DNA damage and other biomarkers in peripheral blood following smoking cessation. Cancer Epidemiol Biomarkers Prev. 1995 Sep;4(6):627–634. [PubMed]
  • Benowitz NL. The use of biologic fluid samples in assessing tobacco smoke consumption. NIDA Res Monogr. 1983;48:6–26. [PubMed]
  • Etzel RA. A review of the use of saliva cotinine as a marker of tobacco smoke exposure. Prev Med. 1990 Mar;19(2):190–197. [PubMed]
  • Pérez-Stable EJ, Benowitz NL, Marín G. Is serum cotinine a better measure of cigarette smoking than self-report? Prev Med. 1995 Mar;24(2):171–179. [PubMed]
  • Benowitz NL, Sharp DS. Inverse relation between serum cotinine concentration and blood pressure in cigarette smokers. Circulation. 1989 Nov;80(5):1309–1312. [PubMed]
  • Thompson SG, Stone R, Nanchahal K, Wald NJ. Relation of urinary cotinine concentrations to cigarette smoking and to exposure to other people's smoke. Thorax. 1990 May;45(5):356–361. [PMC free article] [PubMed]
  • Repace JL, Lowrey AH. An enforceable indoor air quality standard for environmental tobacco smoke in the workplace. Risk Anal. 1993 Aug;13(4):463–475. [PubMed]
  • Idle JR. Titrating exposure to tobacco smoke using cotinine--a minefield of misunderstandings. J Clin Epidemiol. 1990;43(4):313–317. [PubMed]
  • Benowitz NL. Cotinine as a biomarker of environmental tobacco smoke exposure. Epidemiol Rev. 1996;18(2):188–204. [PubMed]
  • Benowitz NL, Hall SM, Herning RI, Jacob P, 3rd, Jones RT, Osman AL. Smokers of low-yield cigarettes do not consume less nicotine. N Engl J Med. 1983 Jul 21;309(3):139–142. [PubMed]
  • Rickert WS, Robinson JC, Collishaw N. Yields of tar, nicotine, and carbon monoxide in the sidestream smoke from 15 brands of Canadian cigarettes. Am J Public Health. 1984 Mar;74(3):228–231. [PMC free article] [PubMed]
  • Benowitz NL, Henningfield JE. Establishing a nicotine threshold for addiction. The implications for tobacco regulation. N Engl J Med. 1994 Jul 14;331(2):123–125. [PubMed]
  • Iwase A, Aiba M, Kira S. Respiratory nicotine absorption in non-smoking females during passive smoking. Int Arch Occup Environ Health. 1991;63(2):139–143. [PubMed]
  • Rando RJ, Menon PK, Poovey HG, Lehrer SB. Assessment of multiple markers of environmental tobacco smoke (ETS) in controlled, steady-state atmospheres in a dynamic test chamber. Am Ind Hyg Assoc J. 1992 Nov;53(11):699–704. [PubMed]
  • Miesner EA, Rudnick SN, Hu FC, Spengler JD, Preller L, Ozkaynak H, Nelson W. Particulate and nicotine sampling in public facilities and offices. JAPCA. 1989 Dec;39(12):1577–1582. [PubMed]
  • Benowitz NL, Jacob P., 3rd Metabolism of nicotine to cotinine studied by a dual stable isotope method. Clin Pharmacol Ther. 1994 Nov;56(5):483–493. [PubMed]
  • Benowitz NL, Jacob P., 3rd Nicotine and cotinine elimination pharmacokinetics in smokers and nonsmokers. Clin Pharmacol Ther. 1993 Mar;53(3):316–323. [PubMed]
  • Levy G, Ebling WF, Forrest A. Concentration- or effect-controlled clinical trials with sparse data. Clin Pharmacol Ther. 1994 Jul;56(1):1–8. [PubMed]
  • Jarvis MJ, Russell MA, Benowitz NL, Feyerabend C. Elimination of cotinine from body fluids: implications for noninvasive measurement of tobacco smoke exposure. Am J Public Health. 1988 Jun;78(6):696–698. [PMC free article] [PubMed]
  • Curvall M, Elwin CE, Kazemi-Vala E, Warholm C, Enzell CR. The pharmacokinetics of cotinine in plasma and saliva from non-smoking healthy volunteers. Eur J Clin Pharmacol. 1990;38(3):281–287. [PubMed]
  • Jarvis M, Tunstall-Pedoe H, Feyerabend C, Vesey C, Salloojee Y. Biochemical markers of smoke absorption and self reported exposure to passive smoking. J Epidemiol Community Health. 1984 Dec;38(4):335–339. [PMC free article] [PubMed]
  • Jarvis MJ, Foulds J, Feyerabend C. Exposure to passive smoking among bar staff. Br J Addict. 1992 Jan;87(1):111–113. [PubMed]
  • Coultas DB, Samet JM, McCarthy JF, Spengler JD. A personal monitoring study to assess workplace exposure to environmental tobacco smoke. Am J Public Health. 1990 Aug;80(8):988–990. [PMC free article] [PubMed]
  • Hammond SK, Sorensen G, Youngstrom R, Ockene JK. Occupational exposure to environmental tobacco smoke. JAMA. 1995 Sep 27;274(12):956–960. [PubMed]
  • Marbury MC, Hammond SK, Haley NJ. Measuring exposure to environmental tobacco smoke in studies of acute health effects. Am J Epidemiol. 1993 May 15;137(10):1089–1097. [PubMed]
  • Henderson FW, Reid HF, Morris R, Wang OL, Hu PC, Helms RW, Forehand L, Mumford J, Lewtas J, Haley NJ, et al. Home air nicotine levels and urinary cotinine excretion in preschool children. Am Rev Respir Dis. 1989 Jul;140(1):197–201. [PubMed]
  • Domino EF, Hornbach E, Demana T. The nicotine content of common vegetables. N Engl J Med. 1993 Aug 5;329(6):437–437. [PubMed]
  • Davis RA, Stiles MF, deBethizy JD, Reynolds JH. Dietary nicotine: a source of urinary cotinine. Food Chem Toxicol. 1991 Dec;29(12):821–827. [PubMed]
  • Repace JL. Dietary nicotine. Won't mislead on passive smoking... BMJ. 1994 Jan 1;308(6920):61–62. [PMC free article] [PubMed]
  • Tunstall-Pedoe H, Woodward M, Brown CA. The drinking, passive smoking, smoking deception and serum cotinine in the Scottish Heart Health Study. J Clin Epidemiol. 1991;44(12):1411–1414. [PubMed]
  • Matsunga SK, Plezia PM, Karol MD, Katz MD, Camilli AE, Benowitz NL. Effects of passive smoking on theophylline clearance. Clin Pharmacol Ther. 1989 Oct;46(4):399–407. [PubMed]
  • Strachan DP, Jarvis MJ, Feyerabend C. Passive smoking, salivary cotinine concentrations, and middle ear effusion in 7 year old children. BMJ. 1989 Jun 10;298(6687):1549–1552. [PMC free article] [PubMed]
  • Strachan DP, Jarvis MJ, Feyerabend C. The relationship of salivary cotinine to respiratory symptoms, spirometry, and exercise-induced bronchospasm in seven-year-old children. Am Rev Respir Dis. 1990 Jul;142(1):147–151. [PubMed]
  • Cook DG, Whincup PH, Papacosta O, Strachan DP, Jarvis MJ, Bryant A. Relation of passive smoking as assessed by salivary cotinine concentration and questionnaire to spirometric indices in children. Thorax. 1993 Jan;48(1):14–20. [PMC free article] [PubMed]
  • Rylander E, Pershagen G, Eriksson M, Bermann G. Parental smoking, urinary cotinine, and wheezing bronchitis in children. Epidemiology. 1995 May;6(3):289–293. [PubMed]
  • Tunstall-Pedoe H, Brown CA, Woodward M, Tavendale R. Passive smoking by self report and serum cotinine and the prevalence of respiratory and coronary heart disease in the Scottish heart health study. J Epidemiol Community Health. 1995 Apr;49(2):139–143. [PMC free article] [PubMed]
  • Hoffmann D, Haley NJ, Adams JD, Brunnemann KD. Tobacco sidestream smoke: uptake by nonsmokers. Prev Med. 1984 Nov;13(6):608–617. [PubMed]
  • Nafstad P, Botten G, Hagen JA, Zahlsen K, Nilsen OG, Silsand T, Kongerud J. Comparison of three methods for estimating environmental tobacco smoke exposure among children aged between 12 and 36 months. Int J Epidemiol. 1995 Feb;24(1):88–94. [PubMed]
  • Jarvis MJ, Russell MA, Feyerabend C. Absorption of nicotine and carbon monoxide from passive smoking under natural conditions of exposure. Thorax. 1983 Nov;38(11):829–833. [PMC free article] [PubMed]
  • Friedman GD, Petitti DB, Bawol RD. Prevalence and correlates of passive smoking. Am J Public Health. 1983 Apr;73(4):401–405. [PMC free article] [PubMed]

Articles from Environmental Health Perspectives are provided here courtesy of National Institute of Environmental Health Science

Formats:

Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...

Links

  • Cited in Books
    Cited in Books
    PubMed Central articles cited in books
  • Compound
    Compound
    PubChem Compound links
  • MedGen
    MedGen
    Related information in MedGen
  • PubMed
    PubMed
    PubMed citations for these articles
  • Substance
    Substance
    PubChem Substance links

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...